2 results
- 14 Apr 2020
54gene Closes $15M Series A
54gene, the African genomics research, services, and development company has closed a Series A round of $15M, led by Adjuvant Capital, a life sciences fund backed by the International Finance…
- 16 Sept 2021
54gene Closes $25M Series B to Advance Global Drug Discovery Capabilities
54gene, the health technology company advancing African genomics research for improved global health outcomes, has secured $25M in a Series B round, led by Cathay AfricInvest Innovation Fund. The…